|
FY2026
12 months to Jun 27, 2026
|
FY2025
12 months to Jun 28, 2025
|
FY2024
12 months to Jun 29, 2024
|
FY2023
12 months to Jun 24, 2023
|
FY2022
12 months to Jun 25, 2022
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Cost of revenue | |||||
| Gross margin | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Acquired intangibles amortization | |||||
| Intangible asset impairment charge | |||||
| Restructuring costs | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Interest and other income, net | |||||
| Interest expense | |||||
| Loss on early extinguishment of debt | |||||
| Gain from sale and leaseback transaction | |||||
| Loss before provision (benefit) for income taxes | |||||
| Provision (benefit) for income taxes | |||||
| Equity investment gain | |||||
| Net (loss) income | |||||
| Net (loss) income per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Shares used in computing net (loss) income per share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...